Evidence map›Paper›PMID 32552921›Full record

ArticleBJPsych open2020

Investigating gender-specific effects of familial risk for attention-deficit hyperactivity disorder and other neurodevelopmental disorders in the Swedish population.

Joanna Martin, Laura Ghirardi, Qi Chen, Catharina A Hartman, Mina A Rosenqvist, Mark J Taylor, Andreas Birgegård, Catarina Almqvist, Paul Lichtenstein, Henrik Larsson

Open access · goldAbstract read
In one paragraph

Article in BJPsych open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Sex and gender in neurodevelopmental conditions.Nature reviews. Neurology · 2023
    Review
  2. Sex differences in anxiety and depression in children with attention deficit hyperactivity disorder: Investigating genetic liability and comorbidity.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Joanna MartinMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK; and Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, Sweden.ORCID https://orcid.org/0000-0002-8911-3479
Laura GhirardiDepartment of Medical Epidemiology & Biostatistics, Karolinska Institutet, Sweden.
Qi ChenDepartment of Medical Epidemiology & Biostatistics, Karolinska Institutet, Sweden.
Catharina A HartmanDepartment of Psychiatry, University Medical Center Groningen, University of Groningen, the Netherlands.
Mina A RosenqvistDepartment of Medical Epidemiology & Biostatistics, Karolinska Institutet, Sweden.
Mark J TaylorDepartment of Medical Epidemiology & Biostatistics, Karolinska Institutet, Sweden.
Andreas BirgegårdDepartment of Clinical Neuroscience, Karolinska Institutet, Sweden.
Catarina AlmqvistDepartment of Medical Epidemiology & Biostatistics, Karolinska Institutet, Sweden; and Pediatric Allergy and Pulmonology Unit at Astrid Lindgren Children's Hospital, Karolinska University Hospital, Sweden.
Paul LichtensteinDepartment of Medical Epidemiology & Biostatistics, Karolinska Institutet, Sweden.
Henrik LarssonDepartment of Medical Epidemiology & Biostatistics, Karolinska Institutet; and School of Medical Sciences, Örebro University, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SEÖrebro University · SEScience for Life Laboratory · SEUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany psychiatric disorders show gender differences in prevalence. Recent studies suggest that female patients diagnosed with anxiety and depression carry more genetic risks related to attention-deficit hyperactivity disorder (ADHD) compared with affected males.

aimsIn this register-based study, we aimed to test whether female patients who received clinical diagnoses of anxiety, depressive, bipolar and eating disorders are at higher familial risk for ADHD and other neurodevelopmental disorders, compared with diagnosed male patients.

methodWe analysed data from a record-linkage of several Swedish national registers, including 151 025 sibling pairs from 103 941 unique index individuals diagnosed with anxiety, depressive, bipolar or eating disorders, as well as data from 646 948 cousin pairs. We compared the likelihood of having a relative diagnosed with ADHD/neurodevelopmental disorders in index males and females.

resultsFemale patients with anxiety disorders were more likely than affected males to have a brother with ADHD (odd ratio (OR) = 1.13, 95% CI 1.05-1.22). Results for broader neurodevelopmental disorders were similar and were driven by ADHD diagnoses. Follow-up analyses revealed similar point estimates for several categories of anxiety disorders, with the strongest effect observed for agoraphobia (OR = 1.64, 95% CI 1.12-2.39). No significant associations were found in individuals with depressive, bipolar or eating disorders, or in cousins.

conclusionsThese results provide modest support for the possibility that familial/genetic risks for ADHD may show gender-specific phenotypic expression. Alternatively, there could be gender-specific biases in diagnoses of anxiety and ADHD. These factors could play a small role in the observed gender differences in prevalence of ADHD and anxiety.

Indexed as

anxiety disordersAttention deficit hyperactivity disordersbipolar affective disordersdepressive disorderseating disorders

Identifiers

PMID32552921
PMCPMC7345736
OpenAlexW3035927723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.